Protective or Inhibitory Effect of Pharmacological Therapy on Cardiac Ischemic Preconditioning: A Literature Review
LJC de Paula, AH Uchida, PC Rezende… - Current Vascular …, 2022 - ingentaconnect.com
Ischemic preconditioning (IP) is an innate phenomenon, triggered by brief, non-lethal cycles
of ischemia/reperfusion applied to a tissue or organ that confers tolerance to a subsequent …
of ischemia/reperfusion applied to a tissue or organ that confers tolerance to a subsequent …
Protective or inhibitory effect of pharmacological therapy on cardiac ischemic preconditioning: a literature review.
LJC de Paula, AH Uchida, PC Rezende… - Current Vascular …, 2022 - europepmc.org
Ischemic preconditioning (IP) is an innate phenomenon, triggered by brief, non-lethal cycles
of ischemia/reperfusion applied to a tissue or organ that confers tolerance to a subsequent …
of ischemia/reperfusion applied to a tissue or organ that confers tolerance to a subsequent …
Protective or Inhibitory Effect of Pharmacological Therapy on Cardiac Ischemic Preconditioning: A Literature Review
LJC de Paula, AH Uchida… - Current vascular …, 2022 - pubmed.ncbi.nlm.nih.gov
Ischemic preconditioning (IP) is an innate phenomenon, triggered by brief, non-lethal cycles
of ischemia/reperfusion applied to a tissue or organ that confers tolerance to a subsequent …
of ischemia/reperfusion applied to a tissue or organ that confers tolerance to a subsequent …
[引用][C] Protective or Inhibitory Effect of Pharmacological Therapy on Cardiac Ischemic Preconditioning: A Literature Review
LJC PAULA, AH UCHIDA… - Current Vascular …, 2022 - observatorio.fm.usp.br
Ischemic preconditioning (IP) is an innate phenomenon, triggered by brief, non-lethal cycles
of ischemia/reperfusion applied to a tissue or organ that confers tolerance to a subsequent …
of ischemia/reperfusion applied to a tissue or organ that confers tolerance to a subsequent …